REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
22/09/2025
Voltar para busca
Dado oficial do USPTO
RTM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
23/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
12/12/2019
Data de registro
22/09/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/09/2020
Última transação
23/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
DINALLO, KEVIN
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Neurimmune Holding AG
Representantes
Janice Housey Litmus Law PLLC
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of nervous system diseasesinfectious diseasesneoplasmsimmune system diseasesendocrine and metabolic diseasescirculatory system diseaseseye diseases; Veterinary preparations for the treatment of nervous system diseasesinfectious diseasesneoplasmsimmune system diseasesendocrine diseasesmetabolic diseasescirculatory system diseaseseye diseases; Pharmaceutical preparations for immunotherapeutic usepharmaceutical agents for the elimination of tumorspharmaceutical preparations for the treatment of neurodegenerative diseasespharmaceutical preparationsimmunogens; Pharmaceutical preparationsantibodies used for the testing of the disease; Vaccines; Diagnostic preparations for medical use in the form of epitopes for detecting protein abnormalities; Pharmaceutical preparationssynthetic peptides used for the treatment of central nervous system diseasesmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; Hygiene preparations for medical usedisinfectants; Biocides; Diagnostic preparations for medical or veterinary use; Sanitary towels for hygiene purposes; Dietetic foods for medical use; Dietetic beverages for medical use; Biological preparations for medical use in the form of protein antibodies directed against specific protein epitopes for use in the treatment of central nervous system diseasesmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunological diseasesinflammatory diseasesrespiratory diseasespsychological diseases; Anti-bacterial preparationsanti-bacterial substances for medical useanti-bacterial pharmaceutical preparationsbio-pharmaceutical preparations for the treatment of cancer; Protein dietary supplements
Classe 42
Monitoringinspection and analysis of biologically active chemicals for quality control purposes; Research in the field of pharmaceutical productscosmetics and foodstuffs for others; Advisory and information services in the field of monitoring and control for purposes of quality control and analysis of biologically active chemicals; Research in the field of medical treatment and medical methods; Research in the field of biotechnology and antibodies; Medical and scientific research in the field of clinical trial review and research with regard to medical treatment; Research in the field of sanitary care; Monitoring and inspection of biological synthesis and pharmaceutical production for quality control purposes and for purposes of scientific research and research in the field of biology; Software design; Computer programming; Maintenance of software; Design and development of computer hardware; Software development; Consultancy and providing of information with respect to quality control of pharmaceutical products; Scientific research in the field of cancerous diseases; Scientific research with respect to chemistry
Classe 44
Medical services; Medical services in the field of immunity; Provision of medical information; Medical examinationsphysical examinations for medical purposes; Pharmaceutical consulting in the manufacture of medicines; Services provided by consultants in nutrition and dietetics; Consultancy and providing of information in the field of sanitary careproviding of health information in connection with health; Veterinary services; Beauty salon services; Animal care servicesveterinary care services; Medical consulting services for hygiene in the field of care; Medical consultancy and providing of medical information with respect to preparationadministration and dosing of pharmaceutical preparations; Consulting services with respect to preparation and administration of pharmaceutical products; Providing medical information for medical staff and for patients in the form of compiled reports in the field of diagnosticprophylactic and therapeutic properties of medicines; Drug testingsystematic testing of medicinal products for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/03/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/07/2021
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
23/01/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/01/2021
FIMP
FINAL DISPOSITION PROCESSED
01/01/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/12/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
22/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/07/2020
PUBO
PUBLISHED FOR OPPOSITION
07/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/05/2020
RFNT
REFUSAL PROCESSED BY IB
17/04/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/03/2020
RFRR
REFUSAL PROCESSED BY MPU
27/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/03/2020
CNRT
NON-FINAL ACTION WRITTEN
12/03/2020
DOCK
ASSIGNED TO EXAMINER
04/03/2020
MAFR
APPLICATION FILING RECEIPT MAILED
01/02/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
31/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/01/2020
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
23/01/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RTM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.